Instructions for Authors
AIDS Research and Human Retroviruses is a peer-reviewed journal in the English language. The Journal will publish Full and Short Communications, Letters to the Editor, Perspectives, Sequence Notes, Mini-reviews, and Conference or Workshop Summaries as deemed appropriate.
Manuscripts must be submitted online using the following url:
http://mc.manuscriptcentral.com/aidsresearch
Please read all the instructions to authors before submitting.
Full Communications should be presented in the format described below.
Short Communications, also subject to peer-review, are intended for the presentation of brief observations that do not warrant a full-length text, but also are not preliminary results. Include an abstract; do not use section headings in the body of the text; report methods, results, and discussion in a single section. Reference citations are identical in style to those of full-length papers, but appropriately abbreviated.
Letters to the Editor can be on any issue relevant to the field of human retroviruses. They must be brief (one or two journal pages) and appropriately documented by data. Letters can be sent to the Editor-in-Chief or to the basic science or clinical Editors, and may be subject to review.
Mini-reviews and Perspectives may be solicited by the Editors or submitted independently. Mini-reviews are brief summaries of new developments in the field of human retroviruses. Perspectives are more representative of an opinion about an area of the field or a direction of research. The length for either should not exceed seven journal pages, and both may be subject to peer-review.
Sequence Notes offer more rapid publication of papers that present novel sequence data in a brief format. They are generally no more than 3 or 4 journal pages. Include an abstract of not more than 150 words, but do not use section headings in the text, and limit the references to 15. Sequence Notes, like all papers, should
be uploaded at: http://mc.manuscriptcentral.com/aidsresearch
Allow 2-3 weeks for the initial evaluation.
Basic Sciences
Molecular Biology
Francine E. McCutchan, Ph.D., Chief, Global Molecular Epidemiology Program, US Military HIV Research Program, Rockville, MD.
Biology
Birgitta Åsjö, M.D., Ph.D., Centre for Research in Virology, University of Bergen, Bergen, Norway.
Pathogenesis
Mario Stevenson, Program in Molecular Medicine, University of Massachusetts Medical School, Worchester, MA.
Vaccines
John Mascola, Rockville, MD.
Animal Models
Ronald C. Desrosiers, Ph.D., New England Regional Primate Research Center, Divisions of Microbiology and Molecular Genetics, Southborough, MA.
Other Human Retroviruses
Mitsuaki Yoshida, Ph.D., Dept. of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Toyko, Kashiwa Chiba, Japan.
Sequence Notes
Brian Foley, Ph.D., HIV Sequence Database, Los Alamos National Laboratory, Los Alamos, NM.
Clinical Investigations
Clinical Trials/Clinical Studies
Carlos del Rio, Emory Center for AIDS Research, Atlanta, GA.
Epidemiology
Mauro Schechter, Hopital Universitario Clementino Fraga Filho, Univer-sidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Editor-in-Chief
Eric Hunter, Ph.D., Emory Vaccine Center, Yerkes National Primate Research Center, 954 Gatewood Road, NE, Atlanta, GA 30329-4208.
Senior Clinical Editor
Michael S. Saag, M.D., UAB AIDS Outpatient Clinic, University of Alabama at Birmingham, Birmingham, AL.
Manuscript Submission and Copyright Agreement Form
The Copyright Agreement form (available from website at http://www.liebertpub.com/media/content/transfer_of_copyright.pdf) should be submitted once your paper has been accepted for publication. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Upon acceptance of your paper, please fax the Copyright Agreement form to 914-740-2108.
Preparation of Manuscript
Follow all submission guidelines to avoid delays in processing and publication. Type manuscripts double-spaced. Leave ample margins on the sides, top, and bottom of the page. Manuscripts should be submitted in Microsoft Word.
The title page should include the authors’ names and affiliations, and a running title of about 45 characters, including spaces. Please indicate contact information for the corresponding author, including a mailing and/or street address, telephone and fax numbers, and e-mail address. The second page must consist of an abstract of not more than 250 words, which should be self-explanatory without reference to the text. Full communications are structured using the following headings: abstract, introduction, materials and methods, results, discussion, acknowledgments, sequence data, and references. Number pages consecutively. At the end of the manuscript, give the name and address of the individual to whom reprint requests should be directed. The inclusion of that person’s e-mail address is also strongly encouraged.
The authors may suggest suitable referees in a cover letter, but must provide accurate contact information for all such individuals, including fax numbers. Please follow the requested style to avoid delays in publication.
Nomenclature
AIDS Research and Human Retroviruses has adopted the recommendations of the Executive Committee of the International Committee on Taxonomy of Viruses (ICTV) (Ref: Science 232:1486, 1986, and Nature 321:644, 1986) to designate viruses associated with AIDS. The Committee’s suggestion was to use HIV (human immunodeficiency virus) or the generic name for this class of human retroviruses. The Committee also recommended maintaining the specific strain names (LAV-1BRU, LAV-1LOI, HTLV-IIIB, HTLV-IIIRF, ARV1 . . .) in the interest of continuity and appreciation for the biologic and molecular differences of the individual strains. Thus, for the sake of accuracy, the editors encourage the use of specific strain names in experimental details.
Sequence Data
AIDS Research and Human Retroviruses requires submission of accession numbers with any manuscript that uses sequence data. The numbers must be listed in a separate section following acknowledgments. Accession numbers can be obtained from Genbank, EMBL, or DDBJ. See http://www.ncbi.nlm.nih.gov/Web/Genbank/submit.html for information, or send e-mail to info@ncbi.nlm.nih.gov
Tables
Submit each table with its title in a separate file. Use Arabic numerals to number tables. Each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Table legends and footnotes should be double-spaced. Information that appears in the text should not be repeated in tables, and tables should not contain data that can be given in the text in one or two sentences.
Illustrations
Figures/images should be presented according to these guidelines:
- Do not include any illustrations as part of your text file.
- Do not prepare any figures in Word as they are not workable.
- Line illustrations must be submitted at 1200 DPI.
- Halftones and color photos should be submitted at 300 DPI.
- Please submit only TIFF, EPS or PDF files.
- Color art must be saved as CYMK not RGB or INDEX. If RGB files are submitted, the files will be converted to CYMK, and some slight color variation may occur.
- Do NOT submit PowerPoint or Excel files. Adobe is the software of choice.
Color Artwork
The Journal will publish color illustrations, but the author must subsidize the cost of the color printing. For further details, contact the Publisher.
Acknowledgments
Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the References section.
AUTHOR DISCLOSURE
All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.
References
All references must be cited in the text. Cite references within the text by a superscript Arabic number. Number references in the order that they appear in the text. Double-space the references and triple-space between each listing. When there are more than six authors, it is acceptable to list the first three followed by “et al.” Use the appropriate styles:
Journals
(1) surname of author(s), initials, (2) paper title, (3) journal, (4) year of publication, (5) volume number, and (6) first and last page of citation. Example: Williams N: T cells on the mucosal frontline. Science 1998;280:198–200.
Books
(1) surname of author(s), initials, (2) chapter title, (3) title of book, (4) editors of book (if applicable), (5) edition of book (if applicable), (6) publisher, (7) city of publication, (8) year of publication, and (9) first and last page reference. Example: Bolognesi D: HIV vaccines. In: Immunology of HIV infection. (Gupta S, ed.) Plenum Medical, New York, 1996, pp. 561–576.
Patents
(1) country of original registration, (2) patent number, (3) month, day, and year of issuance.
When data from an unpublished source are presented, supply complete information, e.g., researcher’s name and location. If work is in press, give the journal in which it is to be published or the publisher.
Permissions
The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the manuscript. All permissions listings must be shown in manuscript—they cannot be entered on proofs.
Fees and Reprints
To help defray the cost of printing, the publisher requests that charges of $65 per printed page be paid by all authors who have funds available from research grants or from their institutions. However, the ability to pay page charges is not a prerequisite for publication. Reprints may be ordered by using the special reprint order form that accompanies the proofs. Reprints ordered after the issue is printed will be charged at a substantially higher rate.
Publisher
The Journal is published monthly by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2108.www.liebertpub.com